Healthcare / Medical Instruments & SuppliesNasdaqCM
$4.05
-0.02 (-0.49%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-1.7M · quality 56.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
32/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$186M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-15.5%
↓Gross Margin
62.3%
↑Debt/Equity
0.21
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2011–2025 · 14 años de histórico normalizado
Revenue CAGR
+16.4%
FCF CAGR
—
FCF margin
-1.2%
FCF / Net income
0.19x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $41.1M · net income $-2.6M · FCF $-494085.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||
| Revenue | $41.1M | $41.1M | $33.6M | $28.5M | $27.9M | $23.5M | $24.2M | $23.2M | $17.4M | — | $12.2M | $11.2M | $8.7M | $7.8M | $6.4M | $4.9M |
| Net Income | $-2.6M | $-2.6M | $-6.1M | $-13.7M | $-8.7M | $-4.6M | $-1.2M | $564349.00 | $910570.00 | $904957.00 | $782864.00 | $753117.00 | $703429.00 | $725763.00 | $815893.00 | $704085.00 |
| EBITDA | $-2.2M | $-2.2M | $-5.6M | $-9.4M | $-10.2M | $-6.6M | $-836190.00 | $925908.00 | $1.5M | $1.5M | $1.5M | $1.4M | $1.2M | $1.3M | $1.4M | $1.3M |
| EPS | -0.06 | -0.06 | -0.13 | -0.30 | -0.19 | -0.10 | -0.03 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Gross Margin | 62.3% | 62.3% | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% | 64.1% | 62.3% | — | 62.1% | 59.5% | 61.0% | — | — | — |
| Operating Margin | -7.2% | -7.2% | -19.2% | -36.0% | -38.6% | -29.9% | -5.2% | 2.5% | 6.7% | — | 9.6% | 10.2% | 11.6% | 13.7% | 20.2% | 24.3% |
| Net Margin | -6.4% | -6.4% | -18.0% | -48.2% | -31.0% | -19.4% | -5.0% | 2.4% | 5.2% | — | 6.4% | 6.7% | 8.1% | 9.3% | 12.8% | 14.3% |
| Balance Sheet | ||||||||||||||||
| Debt/Equity | 0.21 | 0.21 | 0.24 | 0.22 | 0.16 | — | — | — | — | — | — | — | — | 0.09 | 0.12 | — |
| Current Ratio | 2.33 | 2.33 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||
| Free Cash Flow | $-494085.00 | $-494085.00 | $-1.7M | $-5.7M | $-8.2M | — | — | — | — | — | — | $234686.00 | $765702.00 | $221223.00 | $324366.00 | $827943.00 |
| Returns | ||||||||||||||||
| ROE | -15.5% | -15.5% | -36.1% | -67.5% | -27.6% | -12.5% | -3.4% | 5.0% | 10.2% | 11.8% | 11.0% | 12.0% | 13.5% | 16.7% | 23.0% | 28.4% |
| Valuation | ||||||||||||||||
| P/B | 10.97 | 10.97 | 10.62 | 4.95 | 5.49 | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||
| Revenue Growth | 22.2% | 22.2% | 18.0% | 2.2% | — | -2.8% | 4.4% | 33.5% | — | — | 8.9% | 29.3% | 12.0% | 21.5% | 29.9% | — |
| EPS Growth | 53.8% | 53.8% | 56.7% | -57.9% | — | -233.3% | -400.0% | -50.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+45.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.13 → -0.06
Residual
+45.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.